Business Segments · Cost of Sales

Japan, Australia and New Zealand Segment — Cost of Sales

Viatris Japan, Australia and New Zealand Segment — Cost of Sales decreased by 12.4% to $174.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $176.50M to $174.40M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026

How to read this metric

A lower cost of sales relative to revenue indicates higher gross margins and better operational efficiency.

Detailed definition

This metric includes the direct costs attributable to the production and distribution of pharmaceutical products sold wi...

Peer comparison

Standard cost of goods sold metric for regional segments in the pharmaceutical industry.

Metric ID: vtrs_segment_japan_australia_and_new_zealand_segment_cost_of_sales

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$189.40M$207.30M$202.50M$176.50M$181.70M$199.20M$174.40M
QoQ Change+9.5%-2.3%-12.8%+2.9%+9.6%-12.4%
YoY Change-6.8%-12.3%-1.6%-1.2%
Range$174.40M$207.30M
CAGR-5.4%
Avg YoY Growth-5.5%
Median YoY Growth-4.2%

Frequently Asked Questions

What is Viatris's japan, australia and new zealand segment — cost of sales?
Viatris (VTRS) reported japan, australia and new zealand segment — cost of sales of $174.40M in Q1 2026.
How has Viatris's japan, australia and new zealand segment — cost of sales changed year-over-year?
Viatris's japan, australia and new zealand segment — cost of sales decreased by 1.2% year-over-year, from $176.50M to $174.40M.
What does japan, australia and new zealand segment — cost of sales mean?
The direct costs incurred to manufacture and deliver products sold in the Japan, Australia, and New Zealand region.